Cargando…
Deliberate use of placebos in clinical practice: what we really know
Increasingly a focus of research as well as media reports and online forums, the use of placebos in clinical medicine extends beyond sugar pills and saline injections. Physician surveys conducted in various countries invariably report that placebos are routinely used clinically, impure placebos more...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Group
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3386649/ https://www.ncbi.nlm.nih.gov/pubmed/22641788 http://dx.doi.org/10.1136/medethics-2012-100695 |
_version_ | 1782236998193381376 |
---|---|
author | Harris, Cory S Raz, Amir |
author_facet | Harris, Cory S Raz, Amir |
author_sort | Harris, Cory S |
collection | PubMed |
description | Increasingly a focus of research as well as media reports and online forums, the use of placebos in clinical medicine extends beyond sugar pills and saline injections. Physician surveys conducted in various countries invariably report that placebos are routinely used clinically, impure placebos more frequently than the pure ones, and that physicians consider them to be of legitimate therapeutic value. Inconsistent study methodologies and physician conceptualisations of placebos may complicate the interpretation of survey data, but hardly negate the valuable insights these research findings provide. Because impure placebos are often not recognised as such by practitioners, they remain at the fringe of many placebo-related debates, hence quietly absent from discussions concerning policy and regulation. The apparent popularity of impure placebos used in clinical practice thus presents unresolved ethical concerns and should direct future discussion and research. |
format | Online Article Text |
id | pubmed-3386649 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | BMJ Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-33866492012-06-29 Deliberate use of placebos in clinical practice: what we really know Harris, Cory S Raz, Amir J Med Ethics Commentary Increasingly a focus of research as well as media reports and online forums, the use of placebos in clinical medicine extends beyond sugar pills and saline injections. Physician surveys conducted in various countries invariably report that placebos are routinely used clinically, impure placebos more frequently than the pure ones, and that physicians consider them to be of legitimate therapeutic value. Inconsistent study methodologies and physician conceptualisations of placebos may complicate the interpretation of survey data, but hardly negate the valuable insights these research findings provide. Because impure placebos are often not recognised as such by practitioners, they remain at the fringe of many placebo-related debates, hence quietly absent from discussions concerning policy and regulation. The apparent popularity of impure placebos used in clinical practice thus presents unresolved ethical concerns and should direct future discussion and research. BMJ Group 2012-05-28 2012-07 /pmc/articles/PMC3386649/ /pubmed/22641788 http://dx.doi.org/10.1136/medethics-2012-100695 Text en © 2012, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions. This is an open-access article distributed under the terms of the Creative Commons Attribution Non-commercial License, which permits use, distribution, and reproduction in any medium, provided the original work is properly cited, the use is non commercial and is otherwise in compliance with the license. See: http://creativecommons.org/licenses/by-nc/2.0/ and http://creativecommons.org/licenses/by-nc/2.0/legalcode. |
spellingShingle | Commentary Harris, Cory S Raz, Amir Deliberate use of placebos in clinical practice: what we really know |
title | Deliberate use of placebos in clinical practice: what we really know |
title_full | Deliberate use of placebos in clinical practice: what we really know |
title_fullStr | Deliberate use of placebos in clinical practice: what we really know |
title_full_unstemmed | Deliberate use of placebos in clinical practice: what we really know |
title_short | Deliberate use of placebos in clinical practice: what we really know |
title_sort | deliberate use of placebos in clinical practice: what we really know |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3386649/ https://www.ncbi.nlm.nih.gov/pubmed/22641788 http://dx.doi.org/10.1136/medethics-2012-100695 |
work_keys_str_mv | AT harriscorys deliberateuseofplacebosinclinicalpracticewhatwereallyknow AT razamir deliberateuseofplacebosinclinicalpracticewhatwereallyknow |